Sani H. Kizilbash

Also affiliated with WinnMed, Mayo Clinic in Arizona, Mayo Clinic in Florida

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.104Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Analysis of imaging signatures in 18F-DOPA PET of glioblastoma treated with dose-escalated radiotherapy

Frontiers in Oncology(2025)10.3389/fonc.2025.1623313

Top 78%

0.104DataRank

Top 78%1 citations

Deanna Pafundi, William G. Breen, Paul D. Brown, Christopher H. Hunt, Mark Jacobson +16 more

Papers

Driven by 19 papers — median percentile 22. Top paper: “Initial Results of a Phase 2 Trial of 18F-DOPA PET-Guided Dose-Escalated Radiation Therapy for Glioblastoma”.

Initial Results of a Phase 2 Trial of 18F-DOPA PET-Guided Dose-Escalated Radiation Therapy for Glioblastoma

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.03.032

N/A

2.3DataRank · unranked

66 citations

Deanna Pafundi, S. Keith Anderson, Timothy J. Kaufmann, Val J. Lowe, Christopher H. Hunt +15 more

Longitudinal Glioma Monitoring via Cerebrospinal Fluid Cell-Free DNA

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1814

N/A

0.477DataRank · unranked

23 citations

Xiaoxi Dong, Wei Mo, Rahul Kumar, Chao Dai, Lucas P. Carlstrom +22 more

Methodological and analytical considerations for intra-operative microdialysis

Fluids and Barriers of the CNS(2023)10.1186/s12987-023-00497-2

N/A

0.453DataRank · unranked

7 citations

Karishma Rajani, Masum Rahman, Ju‐Hee Oh, Desmond Brown, Jaclyn F. White +8 more

Efficacy of 177Lu-Dotatate Therapy in the Treatment of Recurrent Meningioma

Mayo Clinic Proceedings Innovations Quality & Outcomes(2021)10.1016/j.mayocpiqo.2020.09.015

N/A

0.449DataRank · unranked

19 citations

Derek R. Johnson, Sani H. Kizilbash, Anza Zahid

A hitchhiker’s guide to cerebrospinal fluid biomarkers for neuro-oncology

Neuro-Oncology(2024)10.1093/neuonc/noae276

N/A

0.425DataRank · unranked

16 citations

Michael B. Keough, Jeffrey Zuccato, Rahul Kumar, Sebastian C Schulz, Arthur E. Warrington +14 more

Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without dasatinib for glioblastoma

Neuro-Oncology(2025)10.1093/neuonc/noaf156

N/A

0.273DataRank · unranked

5 citations

Jesse G. Dixon, S. Keith Anderson, Jann N. Sarkaria, Paul D. Brown, Elizabeth Yan +10 more

Personalized Tumor-Specific Amplified DNA Junctions in Peripheral Blood of Patients with High-Grade Gliomas

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3233

N/A

0.165DataRank · unranked

2 citations

Cécile Riviere-Cazaux, Sarah H. Johnson, Rebecca Salvatori, Alan R. Penheiter, James Smadbeck +21 more

Analysis of imaging signatures in 18F-DOPA PET of glioblastoma treated with dose-escalated radiotherapy

Frontiers in Oncology(2025)10.3389/fonc.2025.1623313

Top 78%

0.104DataRank

Top 78%1 citations

Deanna Pafundi, William G. Breen, Paul D. Brown, Christopher H. Hunt, Mark Jacobson +16 more

Cerebrospinal fluid 2-hydroxyglutarate (2-HG) as a monitoring biomarker for IDH-mutant gliomas

medRxiv(2023)10.1101/2023.03.01.23286412

N/A

0.104DataRank · unranked

1 citations

Jean M. Lacey, Lucas P. Carlstrom, William Laxen, Amanda Munoz-Casabella, Matthew D. Hoplin +12 more

Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas

Neuro-Oncology Advances(2023)10.1093/noajnl/vdad061

N/A

0DataRank · unranked

18 citations

Jean M. Lacey, Lucas P. Carlstrom, William Laxen, Amanda Munoz-Casabella, Matthew D. Hoplin +12 more

A phase III randomized, double-blind placebo controlled study of armodafinil (Nuvigil) to reduce cancer-related fatigue in patients with high-grade glioma (Alliance A221101).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12007

N/A

0DataRank · unranked

3 citations

Heshan Liu, Sadhna Kohli, Jane H. Cerhan, Jeff A. Sloan, Ryan P. McMurray +8 more

A first-in-human pharmacodynamic evaluation of dual polyamine depletion for patients with high-grade gliomas.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps2082

N/A

0DataRank · unranked

1 citations

Bryan J. Neth, Sani H. Kizilbash, Terry C. Burns, Cécile Riviere-Cazaux

An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrence

npj Precision Oncology(2023)10.1038/s41698-023-00476-8

N/A

0DataRank · unranked

33 citations

Lucas P. Carlstrom, Bryan J. Neth, Ian Olson, Karishma Rajani, Masum Rahman +15 more

Randomized phase II/III trial of veliparib or placebo in combination with adjuvant temozolomide in newly diagnosed glioblastoma (GBM) patients with MGMT promoter hypermethylation (Alliance A071102).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2001

N/A

0DataRank · unranked

18 citations

Karla V. Ballman, Sani H. Kizilbash, Erik P. Sulman, Caterina Giannini, Sandeep H. Mashru +11 more

Antiangiogenic exclusion rules in glioma trials: Historical perspectives and guidance for future trial design

Neuro-Oncology Advances(2024)10.1093/noajnl/vdae039

N/A

0DataRank · unranked

4 citations

Mahnoor Islam, Mason Webb, Sani H. Kizilbash, Uğur Sener

The early infiltrative phase of GBM hypothesis: are molecular glioblastomas histological glioblastomas in the making? A preliminary multicenter study

Journal of Neuro-Oncology(2022)10.1007/s11060-022-04040-5

N/A

0DataRank · unranked

14 citations

Ricardo A. Domingo, Carlos Perez‐Vega, Michael W. Pullen, Oluwaseun O. Akinduro, João Paulo Almeida +11 more

Predicting Remaining Survival of Glioblastoma Patients with Radiomics Analysis Based on 18F-DOPA PET Images

Cancers(2025)10.3390/cancers17213560

N/A

0DataRank · unranked

1 citations

Deanna Hasenauer, William G. Breen, Paul D. Brown, Christopher H. Hunt, Mark Jacobson +16 more

Disparities in Reported Testing for 1p/19q Codeletion in Oligodendroglioma and Oligoastrocytoma Patients: An Analysis of the National Cancer Database

Frontiers in Oncology(2021)10.3389/fonc.2021.746844

N/A

0DataRank · unranked

1 citations

Panagiotis Kerezoudis, Mohammed Ali Alvi, Yagiz U. Yolcu, Sani H. Kizilbash, Jad Zreik

Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients

Neuro-Oncology Advances(2023)10.1093/noajnl/vdad123

N/A

0DataRank · unranked

16 citations

Bryan J. Neth, Lauren M. Webb, Jamie J. Van Gompel, Michael J. Link, Brian A. Neff +15 more

Sani H. Kizilbash

Indexed papers

Top data-sharing exemplar

Papers